Status:
COMPLETED
Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Major Depressive Disorder
Attention-deficit Hyperactivity Disorder (ADHD)
Eligibility:
All Genders
18+ years
Brief Summary
Poor adherence is a common reason for treatment failure in many fields of medicine, and likely affects common psychiatric treatments as well. Members of the present study team have used Medication Eve...
Eligibility Criteria
Inclusion
- Any male or female, at least 18 years of age, using the Student Health Clinic, with a diagnosis of depression or ADHD.
- Written consent of participation must be given by the subject.
Exclusion
- Subject is less than 18 years of age.
- Inability to complete all study-related visits.
- Introduction of any other prescription medication while participating in the study. (Patients who are on a stable dose of non-study-related prescription medications for at least 4 weeks prior to the study, and throughout the study period, are not excluded.)
- Female patients whose medications may be harmful during pregnancy must be on an acceptable form of birth control, otherwise they will not be eligible for participation.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT01430767
Start Date
September 1 2011
End Date
December 1 2014
Last Update
April 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157